{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Cranbury",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "63031",
      "recalling_firm": "Caraco Pharmaceutical Laboratories Ltd.",
      "address_1": "270 Prospect Plains Rd",
      "address_2": "N/A",
      "postal_code": "08512-3605",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "One direct account - Caraco Pharmaceutical Labroatories, LTD  Detroit, Michigan  78 sub accounts",
      "recall_number": "D-003-2013",
      "product_description": "Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton),  NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.",
      "product_quantity": "a) 2424 Cartons b)  2675 Cartons",
      "reason_for_recall": "Crystallization: Presence of crystals of Nimodipine within the capsule solution.",
      "recall_initiation_date": "20120821",
      "center_classification_date": "20121003",
      "termination_date": "20131119",
      "report_date": "20121010",
      "code_info": "Lot: a) 3305.039B, Exp 07/13; b) 3305.039A, Exp 07/13"
    }
  ]
}